Katherine Baicker Net Worth

Katherine Baicker biography

Dr. Katherine Baicker Ph.D. serves as Independent Director of the Company. She is Professor of Health Economics at the Harvard University School of Public Health, Department of Health Policy and Management; and Research Associate at the National Bureau of Economic Research Dr. Baicker has been a professor of health economics at the Department of Health Policy and Management, School of Public Health, since 2007. From 2005 to 2007, she served as a Senate-confirmed member of the Council of Economic Advisers. From 1998 to 2005, Dr. Baicker was assistant professor and associate professor of economics at Dartmouth College. In 2001 and 2002 she also served as an economist to the Council of Economic Advisers, Executive Office of the President, and in 2003 was a visiting assistant professor at the University of Chicago Harris School of Public Policy. Dr. Baicker is a commissioner of the Medicare Payment Advisory Commission and serves on the Panel of Health Advisers to the Congressional Budget Office. She is a member of the editorial boards of Health Affairs and the Journal of Health Economics, chair of the board of directors of AcademyHealth, editor of the Forum for Health Economics and Policy, and associate editor of the Journal of Economic Perspectives. She is an elected member of the Institute of Medicine.

What is the salary of Katherine Baicker?

As the Independent Director of Lilly(Eli) & Co, the total compensation of Katherine Baicker at Lilly(Eli) & Co is $306,000. There are 11 executives at Lilly(Eli) & Co getting paid more, with David Ricks having the highest compensation of $21,283,200.

How old is Katherine Baicker?

Katherine Baicker is 48, he's been the Independent Director of Lilly(Eli) & Co since 2011. There are 28 older and 2 younger executives at Lilly(Eli) & Co. The oldest executive at Lilly(Eli) & Co is Kathi Seifert, 71, who is the Independent Director.

What's Katherine Baicker's mailing address?

Katherine's mailing address filed with the SEC is Eli Lilly and Company Corporate Center, Indianapolis, Marion County, Indiana, United States.

Insiders trading at Lilly(Eli) & Co

Over the last 20 years, insiders at Lilly(Eli) & Co have traded over $29,994,829,903 worth of Lilly(Eli) & Co stock and bought 73,808 units worth $5,778,435 . The most active insiders traders include Endowment Inc Lilly, R David Hoover und Lorenzo Tallarigo. On average, Lilly(Eli) & Co executives and independent directors trade stock every 7 days with the average trade being worth of $55,447,708. The most recent stock trade was executed by Endowment Inc Lilly on 3 September 2024, trading 24,084 units of LLY stock currently worth $23,281,762.

What does Lilly(Eli) & Co do?

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.

Lilly(Eli) & Co executives and stock owners

Lilly(Eli) & Co executives and other stock owners filed with the SEC include:

• David Ricks,
  Chairman of the Board, President, Chief Executive Officer
• Joshua Smiley,
  Chief Financial Officer, Senior Vice President
• Daniel Skovronsky,
  Senior Vice President, Chief Scientific Officer and President, Lilly Research Laboratories
• David A. Ricks,
  Chairman, CEO & Pres
• Anat Hakim J.D.,
  Sr. VP, Gen. Counsel & Sec.
• Jackson Tai,
  Independent Director
• Juan Luciano,
  Lead Independent Director
• J. Erik Fyrwald,
  Independent Director
• Karen Walker,
  Independent Director
• William Kaelin,
  Independent Director
• Michael Eskew,
  Independent Director
• Jamere Jackson,
  Independent Director
• Katherine Baicker,
  Independent Director
• Raul Alvarez,
  Independent Director
• Kathi Seifert,
  Independent Director
• Marschall Runge,
  Independent Director
• Carolyn Bertozzi,
  Independent Director
• Alfonso Zulueta,
  Senior Vice President, President - Lilly International
• Ilya Yuffa,
  Senior Vice President and President of Lilly Bio-Medicines
• Anne White,
  Senior Vice President, President - Lilly Oncology
• Leigh Pusey,
  Senior Vice President - Corporate Affairs and Communications
• Myles O'Neill,
  Senior Vice President and President - Manufacturing Operations
• Johna Norton,
  Senior Vice President - Global Quality
• Michael Mason,
  Senior Vice President and President, Lilly Diabetes
• Patrik Jonsson,
  Senior Vice President, President of Lilly USA , and Chief Customer Officer
• Stephen Fry,
  Senior Vice President - Human Resources and Diversity
• Anat Hakim,
  Senior Vice President, General Counsel
• Melissa Barnes,
  Senior Vice President - Enterprise Risk Management and Chief Ethics and Compliance Officer
• Aarti Shah,
  Senior Vice President - Chief Information and Digital Officer
• Leigh Ann Pusey,
  Sr. VP of Corp. Affairs & Communications
• Alonzo Weems,
  Sr. VP and Chief Ethics & Compliance Officer
• Diogo Rau,
  Sr. VP & Chief Information and Digital Officer
• Kevin Hern,
  VP of Investor Relations
• Martin Bott MIBS,
  VP of Fin. & Special Projects
• Donald A. Zakrowski,
  Chief Accounting Officer & VP of Fin.
• Jacob S. Van Naarden,
  Chief Operating Officer of Loxo Oncology
• Anat Ashkenazi,
  Sr. VP & CFO
• Eric Dozier,
  EVP, HR & Diversity
• Endowment Inc Lilly,
  
• Christi Shaw,
  SVP and Pres., Lilly Bio-Meds
• Fionnuala M Walsh,
  SVP, Global Quality
• Jan M Lundberg,
  EVP,Science&Tech and Pres. LRL
• Maria A Crowe,
  President, Mfg. Operations
• Ralph Alvarez,
  Director
• Michael J Harrington,
  Senior VP and General Counsel
• Jeffrey N Simmons,
  SVP&Pres.,Elanco Animal Health
• Susan Mahony,
  SVP, HR & Diversity
• Barton R Peterson,
  Sr. VP, Corp. Affairs & Comm.
• Derica W Rice,
  Sr. Vice President and CFO
• Enrique A Conterno,
  Sr. VP & Pres., Lilly Diabetes
• Naarden Jacob Van,
  EVP & Pres., Loxo@Lilly
• Donald A Zakrowski,
  SVP, Finance, & CAO
• Karen N Horn,
  Director
• John C Lechleiter,
  President and COO
• Alonzo Weems,
  EVP, ERM & CECO
• R David Hoover,
  Director
• Franklyn G Prendergast,
  Director
• Ellen R Marram,
  Director
• Douglas R Oberhelman,
  Director
• Anne Nobles,
  Chief Eth/Cmpl Ofcr & SVP, ERM
• Bryce D. Carmine,
  EVP and Pres, Lilly Bio-Meds
• Robert A Armitage,
  Sr. VP and General Counsel
• Steven M Paul,
  EVP, Science and Technology
• Frank M Deane,
  President, Manufacturing
• J Michael Cook,
  Director
• Alfred G Gilman,
  Director
• Martin S Feldstein,
  Director
• Sidney Taurel,
  Chairman, President and CEO
• Alex M Ii Azar,
  Sr. VP, Corp. Affairs & Comm.
• Gino Santini,
  Sr.VP, Corp. Strategy & Policy
• Deirdre P Connelly,
  President, Lilly USA
• Anthony John Murphy,
  Senior VP, Human Resources
• Jacques Tapiero,
  SVP&Pres., Emerging Markets
• Winfried F W Sir Bischoff,
  Director
• Arnold C Hanish,
  Chief Accounting Officer
• Lorenzo Tallarigo,
  President, Internat'l Opers.
• George M C Fisher,
  Director
• Scott A Canute,
  President, Mfg. Operations
• Charles E Golden,
  Exec. Vice President and CFO
• Kimberly H Johnson,
  Director
• Anat Ashkenazi,
  EVP & CFO
• Diogo Rau,
  EVP & CIDO
• Edgardo Hernandez,
  EVP & Pres., Mfg. Operations
• Gabrielle Sulzberger,
  Director
• Mary Lynne Hedley,
  Director
• Melissa Seymour,
  EVP, Global Quality